Endothelin in diabetes-associated atherosclerosis: opportunity 'NOX'.

Cardiovasc Res

Department of Diabetes, Central Clinical School, Monash University, 99 Commercial Road, Melbourne 3004, Australia.

Published: March 2021

Download full-text PDF

Source
http://dx.doi.org/10.1093/cvr/cvab018DOI Listing

Publication Analysis

Top Keywords

endothelin diabetes-associated
4
diabetes-associated atherosclerosis
4
atherosclerosis opportunity
4
opportunity 'nox'
4
endothelin
1
atherosclerosis
1
opportunity
1
'nox'
1

Similar Publications

Should we enlarge the indication for kidney biopsy in patients with diabetes? The pro part.

Clin Kidney J

January 2024

Renal, Dialysis and Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari, Bari, Italy.

Diabetic nephropathy (DN) and non-diabetic renal diseases (NDRD) represent intricate challenges in diagnosis and treatment within the context of the global diabetes epidemic. As the prevalence of diabetes continues to escalate, effective management of renal complications becomes paramount. Recent advancements in comprehending the multifaceted nature of renal damage, fueled by insights from histopathological investigations, offer unprecedented prospects for refining diagnostic strategies and customizing therapeutic interventions.

View Article and Find Full Text PDF

Objective: To research the efficacy of Biejiajian pill (BJJ) on diabetes-associated atherosclerosis and explore its subsequent mechanisms.

Methods: Diabetes-associated atherosclerosis (AS) was established in apolipoprotein E knockout (ApoE ) mice using high-fat diet and streptozotocin. Atorvastatin (ATV, 10 mg/kg/day) or BJJ-L (BJJ low-dose, 0.

View Article and Find Full Text PDF

Endothelin in diabetes-associated atherosclerosis: opportunity 'NOX'.

Cardiovasc Res

March 2021

Department of Diabetes, Central Clinical School, Monash University, 99 Commercial Road, Melbourne 3004, Australia.

View Article and Find Full Text PDF

Endothelin and diabetic complications: a brain-centric view.

Physiol Res

June 2018

Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia, USA, Department of Physiology, Augusta University, Augusta, Georgia, USA.

The global epidemic of diabetes is of significant concern. Diabetes associated vascular disease signifies the principal cause of morbidity and mortality in diabetic patients. It is also the most rapidly increasing risk factor for cognitive impairment, a silent disease that causes loss of creativity, productivity, and quality of life.

View Article and Find Full Text PDF

Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature.

Pharmacol Res

August 2018

Research Service, Harry S Truman Memorial Veterans Hospital, Columbia, MO, USA; Biomedical Sciences, University of Missouri, Columbia, MO, USA; Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA. Electronic address:

Coronary microvascular dysfunction predicts and may be a proximate cause of cardiac dysfunction and mortality in diabetes; however, few effective treatments exist for these conditions. We recently demonstrated that mineralocorticoid receptor (MR) antagonism reversed cardiovascular dysfunction in early-stage obesity/insulin resistance. The mechanisms underlying this benefit of MR antagonism and its relevance in the setting of long-term obesity complications like diabetes; however, remain unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!